P-291NRG1-fusion positive gastrointestinal tumours: afatinib as a novel potential treatment option. (2nd July 2019) - Weinberg, B; Renouf, D; Lim, H; Heining, C; Schlenk, R; Jones, M; Liu, S; Cseh, A; Solca, F; Laskin, J